615
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Highly efficient synthesis and antitumor activity of monosaccharide saponins mimicking components of Chinese folk medicine Cordyceps sinensis

, , , , , , , & show all
Pages 429-435 | Received 05 Aug 2011, Accepted 23 Feb 2012, Published online: 20 Mar 2012
 

Abstract

Ergosterol 3-O-β-d-glucopyranoside (1a) and ergosterol 3-O-β-d-galactopyranoside (1b) were highly efficiently synthesized and evaluated for their inhibitory activities against two tumor cell lines. The structures of these compounds were extensively confirmed by 1H, 13C NMR, IR, and HRMS. Compounds 1a and 1b exhibited interesting cytotoxic profiles. The antitumor activity of compound 1a was higher than that of 1b.

Acknowledgments

This work was financially supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT1166), National Agricultural Innovation Project (No. 2011GB2A100009), Natural Science Foundation of Tianjin City (No. 09JCZDJC21800), the Foundation of Tianjin Educational Committee (No. 20090604), the Scientific and Technical Supporting Programs of Science and Technology Commission Foundation of Tianjin (No. 08ZCGHHZ00800), National Natural Science Foundation of China (NSFC, No. 31000279), and Recruited faculty research start-up foundation in Tianjin University of Science and Technology (No. 0200060).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.